Search Results - Samar Issa

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma

    Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma by Maurilio Ponzoni, Samar Issa, Tracy T. Batchelor, James L. Rubenstein

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Regulation of microRNAs in cancer metastasis

    Regulation of microRNAs in cancer metastasis by Juliette Bouyssou, Salomon Manier, Daisy Huynh, Samar Issa, Aldo M. Roccaro, Irene M. Ghobrial

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Carbazole scaffolds in cancer therapy: a review from 2012 to 2018

    Carbazole scaffolds in cancer therapy: a review from 2012 to 2018 by Samar Issa, Anthony Prandina, Nicolas Bedel, Pål Rongved, Saı̈d Yous, Marc Le Borgne, Zouhair Bouaziz

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation - an International Primary Central Nervous System Lymphoma Study Group project

    Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation - an International Primary Central Nervous System Lymphoma Study Group project by Jacoline E. C. Bromberg, Jeanette K. Doorduijn, Gerald Illerhaus, Kristoph Jahnke, Agnieszka Korfel, L. Fischer, Kristina Fritsch, Outi Kuittinen, Samar Issa, C. van Montfort, Martin J. van den Bent

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI

    Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI by Matthew J. Wieduwilt, Francisco Valles, Samar Issa, Caroline Behler, James Q. Hwang, Michael McDermott, Patrick Treseler, Joan M. O’Brien, Marc A. Shuman, Soonmee Cha, Lloyd E. Damon, James L. Rubenstein

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma

    Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma by James L. Rubenstein, Jane Fridlyand, Lauren E. Abrey, Arthur Shen, Jon Karch, Endi Wang, Samar Issa, Lloyd E. Damon, Michael D. Prados, Michael McDermott, Joan M. O’Brien, Chris Haqq, Marc Shuman

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study

    First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Fo... by Ian W. Flinn, Richard van der Jagt, Brad S. Kahl, Peter Wood, Tim E. Hawkins, David MacDonald, David Simpson, Kathryn S. Kolibaba, Samar Issa, Julie Chang, Judith Trotman, Doreen M. Hallman, Ling Chen, John M. Burke

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience

    Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience by Katharine L. Lewis, Collin K. Chin, Kate Manos, John Casey, Nada Hamad, Julie Crawford, Shir‐Jing Ho, Samar Issa, Andrew Grigg, Peter Wood, Maher K. Gandhi, Bryan Do, Loretta J. Nastoupil, Eliza A. Hawkes, Chan Y. Cheah

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

    Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study by Ian W. Flinn, Richard van der Jagt, Brad S. Kahl, Peter Wood, Tim E. Hawkins, David MacDonald, Mark Hertzberg, Yiu‐Lam Kwan, David Simpson, Michael Craig, Kathryn S. Kolibaba, Samar Issa, Regina Clementi, Doreen M. Hallman, Mihaela Munteanu, Ling Chen, John M. Burke

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

    Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study by Jorge J. Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Toby A. Eyre, Julio C. Chávez, Kenneth H. Shain, Samar Issa, M. Lia Palomba, Oren Pasvolsky, David Simpson, Dipti Talaulikar, Constantine S. Tam, Alessandra Tedeschi, Stephen M. Ansell, Lakshmi Nayak, Steven P. Treon

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets

    TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets by David T Yeung, Michael Osborn, Deborah L. White, Susan Branford, Jodi Braley, Alan Herschtal, Michael Kornhauser, Samar Issa, Devendra Hiwase, Mark Hertzberg, Anthony P. Schwarer, Robin Filshie, Christopher Arthur, Yiu Lam Kwan, Judith Trotman, Cecily Forsyth, John Taper, David M. Ross, J. Beresford, Constantine S. Tam, Anthony K. Mills, Andrew Grigg, Timothy P. Hughes

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: